Drug
14c Berzosertib
14c Berzosertib: highest development phase Phase 1, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C]Berzosertib NCT05246111 | Phase 1 | Advanced Solid Tumor |
Latest
No recent events.
Follow 14c Berzosertib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.